Lukas Küng

Lukas Küng

Auto-generated profile, based on publicly available information

Lukas Küng

Department for BioMedical Research, University of Bern, Bern 3008, Switzerland

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2023 in Science Advances
Verified
Journal Article
Closed access
JTJoanna Triscott
Joanna Triscott
MRMatthias Reist
Matthias Reist
LKLukas Küng
Lukas Küng
FMFrancielle Caroline Mosele
Francielle Caroline Mosele
MLMarika Lehner
Marika Lehner
MRMark A. Rubin
Mark A. Rubin
Phosphatidylinositol (PI)regulating enzymes are frequently altered in cancer and have become a focus for drug development. Here, we explore the phosphatidylinositol-5-phosphate 4-kinases (PI5P4K), a family of lipid kinases that regulate pools of intracellular PI, and demonstrate that the PI5P4Kα isoform influences androgen receptor (AR) signaling, which supports prostate cancer (PCa) cell survival. The regulation of PI becomes increasingly important in the setting of metabolic stress adaptation of PCa during androgen deprivation (AD), as we show that AD influences PI abundance and enhances intracellular pools of PI-4,5-P 2 . We suggest that this PI5P4Kα-AR relationship is mitigated through mTORC1 dysregulation and show that PI5P4Kα colocalizes to the lysosome, the intracellular site of mTORC1 complex activation. Notably, this relationship becomes prominent in mouse prostate tissue following surgical castration. Finally, multiple PCa cell models demonstrate marked survival vulnerability following stable PI5P4Kα inhibition. These results nominate PI5P4Kα as a target to disrupt PCa metabolic adaptation to castrate resistance.

1 October 2005 in Cell Biology International
Verified
Journal Article
Closed access
LAL Ajonuma
L Ajonuma
ENE Ng
E Ng
LCL Chan
L Chan
PCP Chow
P Chow
LKL Kung
L Kung
CHC Haines
C Haines